12. Description of interventions.
| Trial | Intervention | Control | Outcomes | Timing | ||
| Drug | Dose | Frequency | ||||
| Walson 2008 KEN | Albendazole | 400 mg | Once daily for 3 days | Placebo | Viral load CD4 Adverse events Mortality events |
12 weeks |
| Abate 2014 ETH | Albendazole | 400 mg | Once daily for 3 days | Placebo | CD4 Adverse events Mortality events |
12 weeks |
| Kallestrup 2005 ZWE | Praziquantel | 40 mg/kg | Once only | No intervention | Viral load CD4 |
12 weeks |
| Nielsen 2007 TZA | Diethylcarbamazine | 6 mg/kg | Once only | Placebo | Viral load CD4 Adverse events |
12 weeks |
| Kelly 1996 ZMB | Albendazole | 800 mg | Twice daily for 14 days | Placebo | Adverse events Mortality events |
6 months |
| Suputtamongkol 2011 THA | Ivermectin | 200 mg/kg | Single or double dose 2 weeks apart | Albendazole | Adverse events | 1 year |
| Webb 2012 UGA | Albendazole Praziquantel |
400 mg 40 mg/kg |
Once only Once only |
Placebo | Viral load Adverse events Mortality events |
6 weeks |
| Walson 2012 KEN | Albendazole Praziquantel |
400 mg 25 mg/kg |
Every 3 months Annually |
No intervention | Viral load CD4 Adverse events Mortality events |
2 years |